A distinct innate lymphoid cell population regulates tumor-associated T cells.
Crome, Sarah Q; Nguyen, Linh T; Lopez-Verges, Sandra; Yang, S Y Cindy; Martin, Bernard; Yam, Jennifer Y; Johnson, Dylan J; Nie, Jessica; Pniak, Michael; Yen, Pei Hua; Milea, Anca; Sowamber, Ramlogan; Katz, Sarah Rachel; Bernardini, Marcus Q; Clarke, Blaise A; Shaw, Patricia A; Lang, Philipp A; Berman, Hal K; Pugh, Trevor J; Lanier, Lewis L; Ohashi, Pamela S.
; 23(3): 368-375, 2017 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-28165478
Nutrient Competition: A New Axis of Tumor Immunosuppression.
TOX is a critical regulator of tumour-specific T cell differentiation.
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.
The Principles of Engineering Immune Cells to Treat Cancer.
Chromatin states define tumour-specific T cell dysfunction and reprogramming.
Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity.
Metabolic Barriers to T Cell Function in Tumors.
Probing the Diversity of T Cell Dysfunction in Cancer.
Unlocking the Complexities of Tumor-Associated Regulatory T Cells.
Tissue-Resident Cytolytic Innate Lymphocytes in Cancer.